Camarilla Infotech Private Limited provides various services specialized to support & service the 4 Silo's of Marketing (product life cycle) for the Pharmaceutical industry.

During all the stages of the product life cycle Camarilla will support your need for
· Launch materials
· Product Monographs - Print / CD
· Visual Aids
· Presentation slides - Power point / flash
· CD-ROM's/Website development
· Conference coverage - International / National
· Video/audio production

Some of the various activities brought to service the pharmaceutical industry are as follows.

Scientific Updates - Newsletter, Literatures, Clinical Alerts, Case Studies, Journal Abstracts, Therapy Updates etc.

Product Launch Inputs - Product Monographs, Training Manuals, Leave behind literatures, product information websites, Patient education or awareness leaflet/booklets, Reminders, Case Based Posters, Awareness Campaigns, CME / RTM/ PowerPoint presentations, Catalogues etc.

Online Resources - Portals on therapy areas

Camarilla Infotech Private Limited develops unique Health Portals using technology in developing web as an interface to communicate to our end-users.
Camarilla Infotech Private Limited develops class portals in various medical specialties, which include almost all therapy areas.
These are the prominent online resources for physicians and patients/consumers in updating them with latest clinical proceedings internationally & nationally on treatment methods as well their prevention.
Camarilla Infotech Private Limited also develop personalized web pages/sites and websites for physicians and pharmaceutical products during their Launches.

International Conference Updates - All the leading International conferences of all medical specialities are captured via Internet and customize the scientific sessions based on our client needs and delivered in the form of Printables / CD's.

The content developed and designed by us is user friendly with more creative focus as per the requirement of the client and also for the maximum readability by Physicians.

The Conference proceedings /update are exclusively designed as per the Molecule / Therapy/ Product of our client.

Business Intelligence
Camarilla provides business intelligence services in various therapeutic areas. Competitive information is gathered easily and comprehensively with our business intelligence tools.
Camarilla combines in-depth domain expertise, sophisticated analytics and world-class technology to deliver measurable and actionable results that significantly improve the performance of brand portfolios and pharmaceutical sales forces. It provides solutions in sales and marketing tracking, analysis and planning as well as fast-turnaround market research and interactive marketing services.
Our web-based solutions provide a collaborative environment, enabling our global customers to execute efficient and focused sales and marketing programs. Our unique tools and methodologies align tactics with strategy; facilitating faster and more transparent implementation of optimal strategies.

Contract Research
Camarilla provides contract research (CRO) service to facilitate the international CRO companies to expand their operations in India and South East Asia. Contract Research organisation is a particular class of industry which offers independent product development services and also clinical investigation services in new drug development to the pharmaceutical and bio pharmaceutical industries.
All the pharmaceutical companies are facing critical challenges to accelerate drug discovery processes and also to establish competence for their new formulation in a market within short span of time. India with its large and diverse population and a broad spectrum of disease relevant to the global pharmaceutical and biotech markets, offers excellent potential for conducting large and complex clinical trials at low cost.
Camarilla with its customer base, broad presence in web based medical communication offers a platform to International & National Pharmaceutical & Biopharmaceutical companies for their collaborations.
Camarilla will afford services in the area of clinical research that involves testing of new drugs viz., clinical trials, bioavailability and bioequivalence studies and clinical research reports. Our team of experts can process and manage the transition from clinical testing i.e., Phase I till Phase IV and further development swiftly and successfully, providing a preliminary evaluation of pharmacokinetics and pharmacodynamic end points, drug safety and tolerance etc.

Phase I - Inventory phase in recruiting normal human volunteers and special (like renal or hepatic impairment) populations. This phase is primarily carried out by trained clinical pharmacologists to invent the dose range, safety, biological effects, metabolism, and pharmacokinetic profile of the new formulation and also about the drug interactions. (At least 2 subjects should be administered each dose to establish the safe dose range)

Phase II - Exploratory phase where selected patients are enrolled for the particular disease to which the drug is intended for use. The foremost reason for conducting this screening is to evaluate the therapeutic efficacy, dosage range, metabolism and pharmacokinetic nature of the new formulation. (Normally 20-25 patients should be studied for assessment of each dosage)

Phase III - Confirmatory phase where large samples of selected patients of both sexes from multiple centres are registered for the study. This is mainly dose to confirm the safety and efficacy of the formulation. On successful completion of this phase, permission will be granted for marketing the drug.

Phase IV - Post marketing surveillance phase where patients are given drugs for therapy. The main reason for conducting this trial is to evaluate the adverse drug reaction and also the patterns of drug utilization and for additional indications.

Our prospective services will offer 'one roof shop' research in wide range of field viz. toxicological studies, analytical and also post marketing studies to all the pharmaceutical and bio-pharmaceutical companies for lower price tag. The company provides insight and expertise of scientists, clinicians, and regulators, with competencies covering all the aspects of the drug development process. Camarilla under takes traditional clinical trial design and provides high -quality data on time and within budget.

All the pharmaceutical and bio-pharmaceutical companies are experiencing vital challenge to trim down the cost efficiency and also the time consumption in R & D for NEW CHEMICAL ENTITIES (NCE's) approval which helps in launching their new formulation into the market. Global spending for Global clinical outsourcing is estimated at $ 7.8 billion, which is equivalent to 35% of the total spending on development.

Indian Pharmaceutical market is the world's fourth largest by volume of drugs ( 8% of the global market) and 13th largest by value. The prices are among the lowest in the world (Pharma Marketing News, Sept. 2004). In India, 2004 budget gave encouraging gestures for R & D in the pharmaceutical sector particularly in respect of clinical trials. CRO in India is emerging as an acceptable and strategic device for maintaining modernization at the same time meeting expectations for cost and time efficiencies in R & D department by all multinational pharmaceutical industries.

Our importance as a CRO as we are an independent CRO can provide dedicated resources in research, which ultimately allows to focus on the high standards set by the industry, like strict adherence to protocols, excellent clinical practices with GOOD CLINICAL PRACTICE (GLP) guidelines and also complete and accurate documentation.

Camarilla also presents the resulting information in most suitable formats for regulatory submissions. The company also ensures clean data from the very start of the clinical trials and bio equivalence studies, ensuring efficiency of results during final analysis and on ward submissions. This authentic and clean data provide information, necessary for making critical and efficient decisions during the clinical trials. The data mangers and biostatisticians are integral part of the investigating teams and provide a platform for all necessary innovations for accurate and relevant investigations.

Post-marketing Services
Camarilla undertakes all the post-marketing activities of the pharmaceutical companies as open label phase IV trials, Maintenance of safety database, Bio Equivalence studies for generic drugs and post marketing research etc.